ICCC — IMMUCELL CORP /DE/
—
Nasdaq ·
Health Care ·
Life Sciences Tools & Services ·
CIK 811641 ·
Last close
$10.50
Market Cap
$94.99M
52W High
$10.74
52W Low
$6.00
ADV30
31,734
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 10,357,295 | 4,657,444 | 1,969,316 | 1,941,607 | 44,108,374 | 6,812,637 | 14,973,334 |
| Dec 2025 | 7,625,999 | 2,910,209 | -57,956 | -2,849,142 | 42,532,447 | 3,806,831 | 15,476,967 |
| Sep 2025 | 5,506,122 | 2,363,098 | 20,075 | -139,748 | 45,730,123 | 3,886,198 | 15,929,282 |
| Jun 2025 | 6,444,880 | 2,817,924 | 569,562 | 501,880 | 46,720,898 | 5,998,494 | 16,853,470 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$2,475,292
Investing CF
$-1,214,307
Financing CF
$-1,212,386
CapEx
$-1,250,439
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.11
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-15,203,753
Inventory
$9,267,369
Receivables
$3,450,186
ST Investments
—
EBIT TTM
$-578,614
Pretax Income TTM
$-1,028,457
Interest Exp TTM
$449,843
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$29,934,296
EBITDA
$5,882,925
Free Cash Flow
$3,078,906
Enterprise Value
$97,518,352
Total Cash
$6,812,637
Total Debt
$12,777,384
Shares Out
9,046,799
Trailing EPS
$-0.07
Book Value
$2.99
ROE
-1.9%
ROA
4.6%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 27,644,174 | 1,649,305 | -1,040,027 | 42,532,447 | 15,476,967 | — | 2,475,292 |
| Dec 2024 | 26,493,169 | -1,640,159 | -2,156,629 | 45,100,477 | 17,582,290 | — | 357,903 |
| Dec 2023 | 17,471,669 | -5,748,078 | -5,774,598 | 43,808,102 | 18,815,025 | — | -4,674,236 |
| Dec 2022 | 18,567,962 | -2,298,943 | -2,493,805 | 44,860,649 | 14,480,600 | — | -1,543,871 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.11
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| MXCT | MAXCYTE, INC. | $107.12M | $1.00 | — |
| ONMD | OneMedNet Corp | $48.17M | $0.88 | — |
| IMDX | Insight Molecular Diagnostics Inc. | $207.95M | $6.44 | — |
| TKNO | Alpha Teknova, Inc. | $213.92M | $3.99 | — |
| QCLS | Q/C TECHNOLOGIES, INC. | $30.94M | $3.94 | — |
News headlines (Yahoo Finance, 1h cache)
ImmuCell Q1 Earnings Rise Y/Y as Sales Climb on Strong Demand
2026-05-25 13:45 · Yahoo
ImmuCell Corp (ICCC) Q1 2026 Earnings Call Highlights: Record Revenue and Strategic Growth
2026-05-15 23:01 · Yahoo
ImmuCell Q1 Earnings Call Highlights
2026-05-15 15:06 · Yahoo
ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2026
2026-05-14 20:05 · Yahoo
Here’s Why ImmuCell Corporation (ICCC) is Emerging as an Intriguing Micro-Cap Opportunity
2026-05-13 08:18 · Yahoo
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2026
2026-05-07 20:05 · Yahoo
The Zacks Analyst Blog The Goldman Sachs, NextEra, Shopify, Landmark and ImmuCell
2026-04-22 07:59 · Yahoo
Top Stock Reports for Goldman Sachs, NextEra Energy & Shopify
2026-04-21 20:17 · Yahoo
ImmuCell Bolsters its Innovation Strategy with Appointments of Dr. Gilles Guillemette and Dr. Anthony DiMarco to the Board, and Moves to a Smaller Board of Independent Directors
2026-04-13 20:38 · Yahoo
ImmuCell Announces a 28.4% Increase in Product Sales in Q1 of 2026, based on Preliminary, Unaudited Sales Results
2026-04-08 20:05 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.